Vertex Pharmaceuticals Market Sentiment

Vertex Pharmaceuticals Inc

VRTXNASDAQ

$529.69

8.661.66%

Últ. Act.: Oct 29, 4:35 AM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 4 días de ahora en lun nov 2nd, después del cierre del mercado

Conferencia telefónica: Conferencia telefónica programada para dentro de 4 días a las 4:30 p. m.

Haz clic para ver el webcast

Vertex Pharmaceuticals Market Sentiment

Market sentiment signals for Vertex Pharmaceuticals (VRTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.0% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

—

Avg Consensus PT

$544

+0.4%

Highest Price Target

$665

+22.7%

Morgan Stanley

Lowest Price Target

$350

-35.4%

Baird

Short Interest

2.0%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 8, 2026	RBC Capital	Brian Abrahams—	+6.3%	$570 → $576	Maintained	Outperform
Sep 28, 2026	UBS	Michael Yee—	+13.5%	$585 → $615	Maintained	Buy
Sep 11, 2026	JP Morgan	Jessica Fye—	+3.4%	$515 → $560	Reinstates	Overweight
Sep 2, 2026	Morgan Stanley	Terence Flynn—	+22.7%	$665	Reinstates	Overweight
Aug 5, 2026	Truist Securities	Danielle Brill—	+4.3%	$560 → $565	Maintained	Buy
Aug 5, 2026	Barclays	Eliana Merle—	+13.9%	$615 → $617	Maintained	Overweight
Aug 4, 2026	TD Cowen	Phil Nadeau—	+1.5%	$525 → $550	Maintained	Buy
Aug 4, 2026	Cantor Fitzgerald	Carter Gould—	+9.8%	$590 → $595	Maintained	Overweight
Aug 4, 2026	Canaccord Genuity	Whitney Ijem—	-18.4%	$436 → $442	Maintained	Hold
Jul 13, 2026	UBS	Michael Yee—	+8.0%	$545 → $585	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+3.4%	$542 → $560	Maintained	Buy
Jul 7, 2026	RBC Capital	Brian Abrahams—	+5.2%	$543 → $570	Maintained	Outperform
Jul 7, 2026	Baird	Brian Skorney—	-35.4%	$330 → $350	Maintained	Underperform
May 6, 2026	Barclays	Eliana Merle—	+13.5%	$607 → $615	Maintained	Overweight
May 5, 2026	Canaccord Genuity	Whitney Ijem—	-19.5%	$437 → $436	Maintained	Hold
May 5, 2026	Morgan Stanley	Terence Flynn—	+13.7%	$612 → $616	Maintained	Overweight
May 5, 2026	Bernstein	William Pickering—	+5.6%	$577 → $572	Maintained	Outperform
May 5, 2026	RBC Capital	Brian Abrahams—	+0.2%	$541 → $543	Maintained	Outperform
Apr 30, 2026	Canaccord Genuity	Whitney Ijem—	-19.3%	$441 → $437	Maintained	Hold
Apr 10, 2026	Morgan Stanley	Terence Flynn—	+12.9%	$596 → $612	Maintained	Overweight
Mar 18, 2026	Maxim Group	Naz Rahman—	+6.1%	$575	Upgrade	Hold→Buy
Mar 11, 2026	Truist Securities	Joon Lee—	-3.1%	$490 → $525	Maintained	Buy
Mar 10, 2026	Morgan Stanley	Terence Flynn—	+10.0%	$570 → $596	Maintained	Overweight
Mar 10, 2026	B of A Securities	Ying Huang—	+10.4%	$571 → $598	Maintained	Buy
Mar 10, 2026	Citigroup	Geoff Meacham—	+8.0%	$575 → $585	Maintained	Buy